Navigation Links
KalVista Pharmaceuticals and JDRF Form Research Partnership Focused on Novel Approach for Treating Diabetic Eye Disease
Date:1/9/2012

iabetic retinopathy is the most common and most serious eye-related complication of diabetes, and is the leading cause of new cases of legal blindness among adults aged 20 to 74 years in the United States(1). It is a progressive disease that causes retinal swelling and destroys small blood vessels in the retina, eventually leading to vision problems. In its most advanced forms, known as diabetic macular edema and proliferative retinopathy, it can cause moderate to severe vision loss and blindness. According to the National Eye Institute, 40-45 percent of Americans diagnosed with diabetes have some stage of diabetic retinopathy(2).

DME, which involves swelling in the retina that transiently or permanently impairs vision, can occur at any stage of diabetic retinopathy. Treatment to prevent or reverse this condition remains a major unmet clinical need.

The detrimental effects of plasma kallikrein on the retina occur independently of vascular endothelial growth factor (VEGF), which is produced in excessive amounts in people with diabetes and also contributes to the development of diabetic eye disease. VEGF causes leakage in the small blood vessels of the eye that can lead to vision loss and, eventually, blindness. Therapies targeting VEGF are approved for the treatment of DME in Europe and are currently being submitted to the U.S. FDA for approval. However, while intravitreal VEGF inhibitors have shown clear benefit in clinical trials through reducing macular edema and increasing visual acuity, a significant proportion of DME patients do not respond fully to VEGF treatment. KalVista's approach offers the potential to add to the treatment options for sufferers of DME including those that are non-responsive to VEGF inhibitors.

About KalVista Pharmaceuticals

KalVista is a new ophthalmology company with a focus on diabetic macular edema (DME). KalVista is developing novel plasma kallikrein inhibitors, which represents a new approach to th
'/>"/>

SOURCE JDRF
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. KalVista Pharmaceuticals Launched With £8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema
2. Questcor Pharmaceuticals Reports Strong Finish to 2011
3. Valeant Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
4. Radient Pharmaceuticals Announces New Advertisement for Oncology Publications
5. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
6. Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
7. BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
8. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
9. Acella Pharmaceuticals, LLC Announces Its Acquisition of the PRENATE® Family of Trademarks and Associated Intellectual Property
10. Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat
11. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014 Using publicly released ... health plan costs for five common specialty drugs. ... consumers given their high costs and shortage of ... cost thousands per prescription, and are used for ... and multiple sclerosis. HealthPocket found ...
(Date:8/26/2014)... 2014  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and its associated ... to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 ... affects more than 100,000 Americans. As this disease ... gradually lose the ability to breathe, leading ultimately ...
(Date:8/26/2014)... NEW YORK and LONDON ...   FDNA Inc. ( http://www.fdna.com ) ... today that they have partnered to offer, for the ... exclusively through FDNA,s solutions. FDNA, developer of ... fully integrate LMD,s award-winning collection into Face2Gene [ ...
Breaking Medicine Technology:2015 Platinum Plans Are Best Buy for Consumers Using Expensive Specialty Drugs 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3
... ATLANTA, June 7, 2011 CardioMEMS, Inc ., an ... a proprietary wireless sensing and communication technology for the human ... Yadav, M.D. , is a finalist for the 25th annual ... Entrepreneur category. The awards are sponsored by the Metro Atlanta ...
... June 7, 2011 The ALS Therapy Development Institute ... Michael Capuano (D-MA) with its first ever "Lou Gehrig ... gala event this November 3rd.  The award recognizes ... advocate for additional funding for research leading to an ...
Cached Medicine Technology:Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award 2Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award 3U.S. Congressman Michael Capuano to Receive "Lou Gehrig Award" from ALS TDI During Gala Event this November 2
(Date:8/27/2014)... 2014 PCOS (Polycystic Ovarian Syndrome) affects ... at risk for a number of health disorders and ... well understood even within the medical community. Many women ... (hirsutism) and excess body fat around the waist area ... problems are caused by PCOS. , Awareness is the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... PartnerTech AB, a major systems integration and electronics ... Cryotherapy offering the first U.S. designed and ... offered the ideal combination of manufacturing expertise, location, ... system. Impact Cryotherapy, headquartered in Atlanta, GA, offers ...
(Date:8/27/2014)... DeLand, FL (PRWEB) August 27, 2014 *Anyone who ... in DeLand, FL can visit Avail Clinical Research on the web ... Fibromyalgia , Over 5 million Americans are affected by fibromyalgia – ... such as:, Chronic widespread pain , ... Chronic fatigue and sleep problems , Depression , ...
(Date:8/26/2014)... Co (PRWEB) August 27, 2014 Carol ... new cookbook— 100 Best Quick Gluten-Free Recipes (Houghton ... gluten-free meals. , Fenster believes that cooking gluten-free ... understands how today’s busy lifestyle doesn’t leave much time ... that gluten-free cooks ask me is how to shorten ...
(Date:8/26/2014)... Wauwatosa, WI (PRWEB) August 27, 2014 AlignLife ... the month of July. "We had a goal to collect ... Force", Dr. Sara Mahalko said. "Our patients helped us not ... our goal." AlignLife of Wauwatosa collected 559lbs of ... the bar high for next year," explains Dr. Katie Sam. ...
Breaking Medicine News(10 mins):Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 2Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 3Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 2Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 3Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 2Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 3Health News:AlignLife Wauwatosa Thanksgiving in July Yields over 500 lbs of Food 2
... that are commonly referred to as non-communicable diseases could cause ... of the health care cost by 2015, according to estimates ... million people in 2005 to NCD, the toll might reach ... Robert Beaglehole, director of NCD, WHO. ,He was ...
... Pradesh, 136 have been found to be due to ... announced this shocking report in the Assembly. ... identify individuals/health organizations involved in the controversial blood transfusion ... would be implemented to avoid such instances in the ...
... Birth under the Guangdong Family Planning Research Institute in ... discovered 39 cases of new abnormal chromosomes. // ... scientists for genetic and cloning researches. ,Director ... these cases of abnormal chromosomes have been verified by ...
... AIDS/HIV, which is haunting the world for over two decades ... countries in the Asia Pacific // Region would meet in ... treatment and prevention would be the main focus of the ... target to expand AIDS treatment to over 3 million universal ...
... the second leading cause of blindness, worldwide would affect 60 ... end of 2020, // based on a projection in the ... and Africa would be the worst affected by the disabling ... of all glaucoma cases by then. Six out of ...
... treat pneumonia, bronchitis and other infections. Bristol-Myers Squibb Co. ... U.S. Food and Drug Administration said that the drug ... from blood-sugar changes due to this drug. ... of serious cases of hypoglycemia (low blood sugar) and ...
Cached Medicine News:
Athouritative, on the spot answers for acute care and consultations....
The workhorse electric system....
... Knife with BD Xstar Blade includes a ... the blade in prodedure and handling. ... a grind-less process for manufacturing surgical blades. ... and consistency. The arch style, single-bevel ...
... The BD Safety Knife with BD Xstar ... shield that protects the blade in prodedure ... is based on a grind-less process for ... yields outstanding sharpness and consistency. The ...
Medicine Products: